Ophthalmology Times: January 2020
It is imperative for physicians to ensure that patients are receiving the correct medications that they prescribe, and not a generic brand that may not meet the objectives.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages
2
Detecting peripheral retinal lesions in children with myopia
3
Dosing Frequency Across Retinal Vascular Diseases
4
4DMT completes enrollment in 4FRONT-2, global phase 3 trial of 4D-150 in wet AMD
5